Metagenomic studies confirm that obesity is associated with a composition of gut microbiota. There are some controversies, however, about the composition of gut microbial communities in obese individuals in different populations. To examine the association between body mass index and microbiota composition in Ukrainian population, fecal concentrations of Bacteroidetes, Firmicutes, Actinobacteria and Firmicutes/Bacteroidetes (F/B) ratio were analyzed in 61 adult individuals. The relative abundance of Actinobacteria was small (5–7%) and comparable in different BMI categories. The content of Firmicutes was gradually increased while the content of Bacteroidetes was decreased with increasing body mass index (BMI). The F/B ratio also raised with increasing BMI. In an unadjusted logistic regression model, F/B ratio was significantly associated with BMI (OR = 1.23, 95% CI 1,09–1,38). This association continued to be significant after adjusting for confounders such as age, sex, tobacco smoking and physical activity (OR = 1.33, 95% CI 1,11–1,60). The obtained data indicate that obese persons in Ukraine adult population have a significantly higher level of Firmicutes and lower level of Bacteroidetes compared to normal-weight and lean adults.

Background. Intestinal dysbiosis is associated with violating both quantitative and qualitative intestinal microbiome (IM) composition. It accompanies different gastrointestinal disorders, including non-celiac gluten sensitivity (NCGS) and celiac disease (CD). A gluten-free diet is the only existing treatment for CD and NCGS. One of the questions of interest is the characteristics of the IM of patients with gluten-related diseases and its relationship with diet therapy. Materials and methods. The study included 25 adults, 14 (56 %) with CD and 11 (44 %) with NCGS; all were on agliadin diet. We determined the faecal content of the Bacteroidetes, Firmicutes, and Actinobacteria and the rest bacterial DNA (“other” indicator) using the real-time polymerase chain reaction. Results. The Bacteroidetes content was 28.4 (Q1-Q3 9.195–37.83) % in CD and 24.98 (Q1-Q3 9.615–30.597) % in NCGS patients, p = 0.565. Firmicutes content was 53.47 (Q1-Q3 49.98–56.798) % in CD patients and 53.0 (Q1-Q3 48.12–68.53) % in NCGS, p = 0.763. The Actinobacteria content was 4.8 (Q1-Q3 3.82–6.84) % in CD patients and 5.37 (Q1-Q3 4.09–7.77) % in NCGS, p = 0.572. There was a moderate positive correlation with the diet duration (p = 0.397, p = 0.03). The Firmicutes/Bacteroidetes ratio was 1.996 (Q1-Q3 1.35–6.85) in CD patients and 2.0 (Q1-Q3 1.65–7.58) in NCGS patients, p = 0.681. The content of “other” types of IM was 15.39 (Q1-Q3 7.44–22.33) % in CD patients and 13.78 (Q1-Q3 10.65–15.58) % in NCGS patients, p = 0.936. Conclusions. We found similar intestinal microbiome features in patients with celiac disease and non-celiac gluten sensitivity. The detected intestinal microbiome changes are most likely to be a consequence of dietary features in such patients, namely the side effect of maintaining an agliadin diet.

Human interferon α-2b (HuIFNα-2b) is a cytokine with antiviral and antiproliferative activities and is widely used as a therapeutic protein. Here, we investigated the production of biologically active HuIFNα-2b in transgenic tomato plants. Long-shelf-life Solanum lycopersicum L. cv. ‘Shedevr 1’ plants were transformed via an Agrobacterium-mediated protocol using the binary vector pCB124 carrying nptII and HuIFNα-2b genes. PCR and RT-PCR analyses confirmed transgenes presence and expression in regenerated kanamycin-resistant plants. Antiviral activity was evaluated in vitro by the inhibition of vesicular stomatitis virus replication in MA-104 epithelial cells. Interferon activity reached 14.90 × 10³ IU g⁻¹ FW in fresh fruit pulp and 854.00 × 10³ IU g⁻¹ FW in leaves. Importantly, transgenic fruits retained substantial activity (2.42 × 10³–6.72 × 10³ IU g⁻¹ FW) after three months of storage, with detectable activity (0.36 × 10³ IU g⁻¹ FW) remaining after five months. Transgene inheritance and interferon activity were confirmed in the T₁ and T₂ generations. These results demonstrate the potential of long-shelf-life transgenic tomatoes as a platform for the production and extended storage of biologically active recombinant proteins, potentially reducing dependence on costly purification and cold storage procedures.